Elekta AB (publ) (EKTAY)

7.03 -0.01 (-0.18%) At close: 03:09PM EDT

Elekta AB (publ)

Kungstensgatan 18
Box 7593
Stockholm 103 93
Sweden
46 8 58 72 54 00
https://elekta.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 4,584

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Laurent Leksell	Founder & Chairman	1.64M	N/A	1952
Mr. Gustaf Salford	President & CEO	14.62M	N/A	1977
Mr. Tobias Hagglov	Chief Financial Officer	N/A	N/A	1978
Mr. Peter Nyquist	Head of Investor Relations	N/A	N/A	1965
Mr. Jonas Bolander	Executive VP of Group Functions, Secretary & General Counsel	N/A	N/A	1966
Mr. Mattias Thorsson	VP and Head of Corporate Communications & Public Affairs	N/A	N/A	N/A
Ms. Anna Conneryd Lundgren	Executive VP & Chief People Officer	N/A	N/A	1985
Mr. John Lapré	President of Brachy & Neuro Solutions	N/A	N/A	1964
Mr. Maurits Wolleswinkel	President of Linac & Software Solutions	N/A	N/A	1971
Mr. Habib Nehme	Chief Commercial Officer	N/A	N/A	1964

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Corporate governance

Elekta AB (publ)’s ISS governance QualityScore as of 1 May 2024 is 5. The pillar scores are Audit: 5; Board: 7; Shareholder rights: 8; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.